AGILINK develops dexterous robotic hands and grippers for humanoids, industrial robots and embodied-AI developers. It confirmed nearly RMB 1B in cumulative financing across four rounds by June 2026, reached an about US$1B valuation and said OmniHand deliveries had exceeded 8,000 units since January.
AGILINK matters because dexterous end-effectors are a core bottleneck for useful humanoid and mobile-manipulation deployment, and the reported shipment scale makes it one of the more visible Chinese hand suppliers.